These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20472479

  • 21. Inhibition of binding of ovine placental lactogen to growth hormone and prolactin receptors by monoclonal antibodies.
    Chan JS, Nie ZR, Seidah NG, Chrétien M.
    Endocrinology; 1986 Dec; 119(6):2623-8. PubMed ID: 2430784
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties.
    Binder L, Gertler A, Elberg G, Guy R, Vogel T.
    Mol Endocrinol; 1990 Jul; 4(7):1060-8. PubMed ID: 2178223
    [Abstract] [Full Text] [Related]

  • 24. Prolactin (PRL) receptor induction in cultured rat hepatocytes: dual regulation by PRL and growth hormone.
    Barash I, Cromlish W, Posner BI.
    Endocrinology; 1988 Mar; 122(3):1151-8. PubMed ID: 3342748
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biochemistry and pharmacology of rabbit cardiac growth hormone (GH) receptors.
    Haro LS, Bustamante J, Hernandez P, Flores R, Aguilar R, Lopez-Guajardo C, Martinez AO.
    Mol Cell Endocrinol; 1999 Jun 25; 152(1-2):179-87. PubMed ID: 10432235
    [Abstract] [Full Text] [Related]

  • 27. Human growth hormone-variant is a biologically active somatogen and lactogen.
    MacLeod JN, Worsley I, Ray J, Friesen HG, Liebhaber SA, Cooke NE.
    Endocrinology; 1991 Mar 25; 128(3):1298-302. PubMed ID: 1999151
    [Abstract] [Full Text] [Related]

  • 28. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor.
    Peterson FC, Brooks CL.
    Protein Eng Des Sel; 2004 May 25; 17(5):417-24. PubMed ID: 15252206
    [Abstract] [Full Text] [Related]

  • 29. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G, Reicher S, Gussakovsky EE, Jomain JB, Gertler A.
    Growth Horm IGF Res; 2006 May 25; 16(5-6):297-307. PubMed ID: 17010651
    [Abstract] [Full Text] [Related]

  • 30. Binding and structural characteristics of a soluble lactogen-binding protein from rabbit mammary-gland cytosol.
    Ymer SI, Herington AC.
    Biochem J; 1986 Aug 01; 237(3):813-20. PubMed ID: 3800919
    [Abstract] [Full Text] [Related]

  • 31. Characterization of dimeric forms of human pituitary growth hormone by bioassay, radioreceptor assay, and radioimmunoassay.
    Brostedt P, Luthman M, Wide L, Werner S, Roos P.
    Acta Endocrinol (Copenh); 1990 Feb 01; 122(2):241-8. PubMed ID: 2316312
    [Abstract] [Full Text] [Related]

  • 32. Characterization of prolactin- and growth hormone-binding proteins in milk and their diversity among species.
    Amit T, Dibner C, Barkey RJ.
    Mol Cell Endocrinol; 1997 Jun 20; 130(1-2):167-80. PubMed ID: 9220032
    [Abstract] [Full Text] [Related]

  • 33. Pituitary regulation of human growth hormone binding sites in rat liver membranes.
    Herington AC, Phillips LS, Daughaday WH.
    Metabolism; 1976 Mar 20; 25(3):341-53. PubMed ID: 175242
    [Abstract] [Full Text] [Related]

  • 34. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes.
    Vashdi-Elberg D, Staten NR, Sakal E, Krivi GG, Gertler A.
    Endocrinology; 1995 Mar 20; 136(3):1258-66. PubMed ID: 7867580
    [Abstract] [Full Text] [Related]

  • 35. Radioreceptor assay of human prolactin using rabbit mammary receptors.
    Simionescu L, Zamfir-Grigorescu D, Dimitriu V, Dumitriu E, Marcean-Petrescu R, Dragomirescu E, Ionescu T.
    Endocrinologie; 1987 Mar 20; 25(4):199-208. PubMed ID: 3432986
    [Abstract] [Full Text] [Related]

  • 36. Relative localization of the prolactin receptor binding sites for lactogenic hormones.
    Longhi SA, Blank VC, Roguin LP, Cristodero M, Retegui LA.
    Growth Horm IGF Res; 2001 Oct 20; 11(5):324-8. PubMed ID: 11735251
    [Abstract] [Full Text] [Related]

  • 37. Interaction of recombinant rat placental lactogen-I with extracellular domains of prolactin receptors from three species.
    Sakal E, Robertson MC, Chapnik-Cohen N, Tchelet A, Gertler A.
    Recept Signal Transduct; 1996 Oct 20; 6(1):35-42. PubMed ID: 8933620
    [Abstract] [Full Text] [Related]

  • 38. Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion.
    Zhang F, Zhang Q, Tengholm A, Sjöholm A.
    Am J Physiol Cell Physiol; 2006 Sep 20; 291(3):C466-75. PubMed ID: 16597920
    [Abstract] [Full Text] [Related]

  • 39. Mechanism-based design of prolactin receptor antagonists.
    Fuh G, Colosi P, Wood WI, Wells JA.
    J Biol Chem; 1993 Mar 15; 268(8):5376-81. PubMed ID: 8449901
    [Abstract] [Full Text] [Related]

  • 40. Activity of alkylated prolactin and human growth hormone in receptor and cell assays.
    Necessary PC, Andersen TT, Ebner KE.
    Mol Cell Endocrinol; 1985 Mar 15; 39(3):247-54. PubMed ID: 2984068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.